David V. Goeddel
CHAIRMAN
biotechnology
NGM Biopharmaceuticals Inc
United States of America
Biography
Dr. Goeddel has served as chairman of our board of directors since January 2008 and served as our Chief Executive Officer from 2008 to 2010. Dr. Goeddel has been Managing Partner of The Column Group since 2007. He co-founded Tularik in 1991, was Vice President of Research until 1996 and Chief Executive Officer from 1996 through 2004, when Tularik was acquired by Amgen. He served as Amgen’s first Senior Scientific Vice President until May 2006. Prior to Tularik, he was the first scientist hired by Genentech, Inc. and from 1978 to 1993 served in various positions, including Fellow, Staff Scientist and Director of Molecular Biology.
Research Interest
Biotechnology
